Q-omics provides the consensus-scored NDUFB4P8 profile across patient tissues and cancer cell-line models. NDUFB4P8 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, NDUFB4P8 is differentially expressed in 3, with the highest sampling consensus in THCA. Additionally, NDUFB4P8 RNA expression shows 8,978 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight KICH, THCA, and UVM as cancer lineages where NDUFB4P8 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for NDUFB4P8 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes NDUFB4P8 survival associations across molecular data types. NDUFB4P8 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible NDUFB4P8 RNA expression–survival associations across cancer types. High NDUFB4P8 expression shows unfavorable associations in KICH, DLBC, ACC, LGG and KIRC, but favorable associations in KIRP. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for NDUFB4P8 RNA expression.
This table summarizes NDUFB4P8 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for NDUFB4P8. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. NDUFB4P8 shows lower tumor expression in THCA and higher tumor expression in LIHC and STAD. The THCA box plot shows higher NDUFB4P8 RNA expression in normal versus tumor tissue (log2 FC = −0.156, t-test p = .004).
This table shows molecular features associated with NDUFB4P8 in patient tissues and cancer cell lines. In patient samples, NDUFB4P8 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
